3M CO (MMM) Borrowing debt
- Total debt · latest quarter (USD): Value (m); Formula and calculation Current and noncurrent long-term debt plus complete reported short-term borrowings (commercial paper alone when no complete total is admitted). Period ending 2026-06-30..
- Net cash · latest quarter: Value (m); Formula and calculation Cash and cash equivalents plus current marketable securities less interest-bearing debt; negative net cash is displayed as net debt. Period ending 2026-06-30..
- Debt / assets · latest quarter: Value (m); Formula and calculation Current and noncurrent long-term debt plus complete reported short-term borrowings (commercial paper alone when no complete total is admitted) / total assets. Period ending 2026-06-30..
Borrowing debt
Overview →Financial period ending 2026-06-30; current quote (m). Amounts retain their stated periods and units.
| Metric | Value | Formula and calculation |
|---|---|---|
| Total debt · latest quarter (USD) | (m) | Current and noncurrent long-term debt plus complete reported short-term borrowings (commercial paper alone when no complete total is admitted). Period ending 2026-06-30. Calculation unavailable: missing inputs remain (m). |
| Net cash · latest quarter | (m) | Cash and cash equivalents plus current marketable securities less interest-bearing debt; negative net cash is displayed as net debt. Period ending 2026-06-30. Calculation unavailable: missing inputs remain (m). |
| Debt / assets · latest quarter | (m) | Current and noncurrent long-term debt plus complete reported short-term borrowings (commercial paper alone when no complete total is admitted) / total assets. Period ending 2026-06-30. Calculation unavailable: missing inputs remain (m). |
Calculation inputs
| Input | Amount with unit | Raw financial data |
|---|---|---|
| Borrowing debt due within one year | (m) | Long-term Debt, Current Maturities |
| Borrowing debt due after one year | 10.90B USD | Long-term Debt, Excluding Current Maturities |
| Commercial paper | (m) | Commercial Paper |
| Cash and current securities | (m) | Cash and Cash Equivalents, at Carrying Value · Marketable Securities, Current · Available-for-sale Securities, Current |
| Borrowing debt | (m) | Long-term Debt, Current Maturities · Long-term Debt, Excluding Current Maturities · Commercial Paper |
| Total assets | 34.92B USD | Assets |
Calculated history
Changes compare with the next older row (previous quarter), unless explicitly labeled otherwise. Rolling 12-month growth compares two successive quarter-end rolling totals; it is not year-over-year growth.
| Period ending | Total debt | Net cash / debt | Borrowing debt due within one year (USD) | Borrowing debt due after one year (USD) | Commercial paper (USD) | Cash and current securities (USD) | Total assets (USD) | Debt / assets |
|---|---|---|---|---|---|---|---|---|
| 2026-06-30 | (m) | (m) | (m) | $10.90B | (m) | (m) | $34.92B | (m) |
| 2026-03-31 | (m) | (m) | (m) | $10.91B | (m) | (m) | $35.44B | (m) |
| 2025-12-31 | (m) | (m) | $1.67B | $10.93B | (m) | (m) | $37.73B | (m) |
| 2025-09-30 | (m) | (m) | (m) | $11.85B | (m) | (m) | $37.61B | (m) |
| 2025-06-30 | (m) | (m) | (m) | $12.48B | (m) | (m) | $37.99B | (m) |
| 2025-03-31 | (m) | (m) | (m) | $12.31B | (m) | (m) | $39.95B | (m) |
| 2024-12-31 | (m) | (m) | $1.92B | $11.13B | (m) | (m) | $39.87B | (m) |
| 2024-09-30 | (m) | (m) | (m) | $11.32B | (m) | (m) | $40.88B | (m) |
| 2024-06-30 | (m) | (m) | (m) | $11.78B | (m) | (m) | $43.38B | (m) |
| 2024-03-31 | (m) | (m) | (m) | $20.59B | (m) | (m) | $55.24B | (m) |
| 2023-12-31 | (m) | (m) | $1.15B | $13.09B | (m) | (m) | $50.58B | (m) |
| 2023-09-30 | (m) | (m) | (m) | $12.88B | (m) | (m) | $49.62B | (m) |
| 2023-06-30 | (m) | (m) | (m) | $12.95B | (m) | (m) | $48.88B | (m) |
| 2023-03-31 | (m) | (m) | (m) | $12.95B | (m) | (m) | $46.89B | (m) |
| 2022-12-31 | (m) | (m) | $1.94B | $14.00B | (m) | (m) | $46.45B | (m) |
| 2022-09-30 | (m) | (m) | (m) | $13.85B | (m) | (m) | $46.18B | (m) |
| 2022-06-30 | (m) | (m) | (m) | $14.02B | (m) | (m) | $45.63B | (m) |
| 2022-03-31 | (m) | (m) | (m) | $14.80B | (m) | (m) | $45.85B | (m) |
| 2021-12-31 | (m) | (m) | $1.29B | $16.06B | (m) | (m) | $47.07B | (m) |
| 2021-09-30 | (m) | (m) | (m) | $16.19B | (m) | (m) | $48.28B | (m) |
| 2021-06-30 | (m) | (m) | (m) | $16.27B | (m) | (m) | $48.31B | (m) |
| 2021-03-31 | (m) | (m) | (m) | $16.82B | $0.00 | (m) | $47.18B | (m) |
| 2020-12-31 | (m) | (m) | (m) | $17.99B | (m) | (m) | $47.34B | (m) |
| 2020-09-30 | (m) | (m) | (m) | $18.43B | (m) | (m) | $45.39B | (m) |
| 2020-06-30 | (m) | (m) | (m) | $19.28B | (m) | (m) | $45.08B | (m) |
| 2020-03-31 | (m) | (m) | (m) | $19.25B | (m) | (m) | $46.21B | (m) |
| 2019-12-31 | (m) | (m) | (m) | $17.52B | (m) | (m) | $44.66B | (m) |
| 2019-09-30 | (m) | (m) | (m) | $17.48B | (m) | (m) | $42.55B | (m) |
| 2019-06-30 | (m) | (m) | (m) | $14.91B | (m) | (m) | $38.97B | (m) |
| 2019-03-31 | (m) | (m) | (m) | $15.58B | (m) | (m) | $39.14B | (m) |
| 2018-12-31 | (m) | (m) | (m) | $13.41B | (m) | (m) | $36.50B | (m) |
| 2018-09-30 | (m) | (m) | (m) | $13.54B | (m) | (m) | $37.27B | (m) |
| 2018-06-30 | (m) | (m) | (m) | $11.29B | (m) | (m) | $36.78B | (m) |
| 2018-03-31 | (m) | (m) | (m) | $12.21B | (m) | (m) | $38.58B | (m) |
| 2017-12-31 | (m) | (m) | (m) | $12.10B | (m) | (m) | $37.99B | (m) |
| 2017-09-30 | (m) | (m) | (m) | $10.83B | (m) | (m) | $35.24B | (m) |
| 2017-06-30 | (m) | (m) | (m) | $11.09B | (m) | (m) | $33.96B | (m) |
| 2017-03-31 | (m) | (m) | (m) | $10.80B | (m) | $2.31B | $33.29B | (m) |
| 2016-12-31 | (m) | (m) | (m) | $10.68B | (m) | $2.68B | $32.91B | (m) |
| 2016-09-30 | (m) | (m) | (m) | $11.08B | (m) | $2.67B | $34.05B | (m) |
| 2016-06-30 | (m) | (m) | (m) | $9.30B | (m) | $1.86B | $33.23B | (m) |
| 2016-03-31 | (m) | (m) | (m) | $8.93B | (m) | $1.51B | $32.98B | (m) |
| 2015-12-31 | (m) | (m) | (m) | $8.75B | (m) | $1.92B | $32.72B | (m) |
| 2015-09-30 | (m) | (m) | (m) | $8.97B | (m) | $1.76B | $33.26B | (m) |
| 2015-06-30 | (m) | (m) | (m) | $8.43B | (m) | $3.48B | $31.39B | (m) |
| 2015-03-31 | (m) | (m) | (m) | $6.46B | (m) | $2.81B | $30.64B | (m) |
| 2014-12-31 | (m) | (m) | (m) | $6.73B | (m) | $2.52B | $31.27B | (m) |
| 2014-09-30 | (m) | (m) | (m) | $5.22B | (m) | $2.70B | $32.78B | (m) |
| 2014-06-30 | (m) | (m) | (m) | $5.32B | (m) | $3.01B | $33.97B | (m) |
| 2014-03-31 | (m) | (m) | (m) | $4.40B | (m) | $2.81B | $33.55B | (m) |
| 2013-12-31 | (m) | (m) | (m) | $4.33B | (m) | $3.34B | $33.55B | (m) |
| 2013-09-30 | (m) | (m) | (m) | $3.53B | (m) | $3.31B | $33.60B | (m) |
| 2013-06-30 | (m) | (m) | (m) | $4.88B | (m) | $4.25B | $34.13B | (m) |
| 2013-03-31 | (m) | (m) | (m) | $4.86B | (m) | $4.38B | $34.03B | (m) |
| 2012-12-31 | (m) | (m) | (m) | $4.92B | (m) | $4.53B | $33.88B | (m) |
| 2012-09-30 | (m) | (m) | (m) | $4.85B | (m) | $5.02B | $34.48B | (m) |
| 2012-06-30 | (m) | (m) | (m) | $5.66B | (m) | $4.90B | $33.34B | (m) |
| 2012-03-31 | (m) | (m) | (m) | $4.51B | (m) | $3.73B | $32.02B | (m) |
| 2011-12-31 | (m) | (m) | (m) | $4.48B | (m) | $3.68B | $31.62B | (m) |
| 2011-09-30 | (m) | (m) | (m) | $4.96B | (m) | $4.86B | $32.12B | (m) |
| 2011-06-30 | (m) | (m) | (m) | $4.48B | (m) | $4.52B | $32.28B | (m) |
| 2011-03-31 | (m) | (m) | (m) | $4.49B | (m) | $4.03B | $31.13B | (m) |
| 2010-12-31 | (m) | (m) | (m) | $4.18B | (m) | $4.48B | $30.16B | (m) |
| 2010-09-30 | (m) | (m) | (m) | $5.11B | (m) | $5.85B | $30.07B | (m) |
| 2010-06-30 | (m) | (m) | (m) | $4.95B | (m) | $4.93B | $28.50B | (m) |
| 2010-03-31 | (m) | (m) | (m) | $5.08B | (m) | $4.61B | $28.02B | (m) |
| 2009-12-31 | (m) | (m) | (m) | $5.10B | (m) | $3.78B | $27.25B | (m) |
| 2009-09-30 | (m) | (m) | (m) | $5.20B | (m) | $3.94B | $27.63B | (m) |
| 2009-06-30 | (m) | (m) | (m) | $5.17B | (m) | $2.97B | $26.09B | (m) |
| 2008-12-31 | (m) | (m) | (m) | $5.17B | (m) | $2.22B | $25.79B | (m) |
(m) means missing inputs. Historical market-based ratios use the saved close on or immediately before period ending and that period’s reported shares; current quotes are not substituted. Five-year projections repeat historical CAGR, not analyst forecasts.
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| STRYKER CORP (SYK) | United States | $103.511B | 32.39 |
| BOSTON SCIENTIFIC CORP (BSX) | United States | $64.781B | 17.29 |
| BECTON DICKINSON & CO (BDX) | United States | $48.834B | 43.79 |
| DEXCOM INC (DXCM) | United States | $33.004B | 25.42 |
| WEST PHARMACEUTICAL SERVICES INC (WST) | United States | $26.288B | 43.14 |
| Solventum Corp (SOLV) | United States | $15.085B | 9.16 |
| Penumbra Inc (PEN) | United States | $12.596B | 77.33 |
| BAXTER INTERNATIONAL INC (BAX) | United States | $12.139B | -10.35 |
| GLOBUS MEDICAL INC (GMED) | United States | $9.977B | 20.03 |
| INSULET CORP (PODD) | United States | $9.420B | 28.12 |